I get asked a lot of questions about what California cannabis licensees can and cannot do under the Medicinal and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”). California is actually business friendly once operations get going with a license– despite its many issues with the cannabis industry. For example, vertical integration is allowed. There’s no
Exciting developments lie ahead for European Union (EU) marijuana legalization. It is inevitable that marijuana legalization sweeps the globe–if you haven’t seen it yet, please watch our webinar with Clifford Chance about the existing global economy of marijuana. The question is just one of timing. In Germany, as one prominent example, we’re looking at legalization
California cannabis tax relief is a big deal. And a real thing. What’s important now is how the California Department of Tax and Fee Administration (“CDTFA”) interprets Assembly Bill 195. As I previously blogged, California is finally on board with a modicum of cannabis tax relief for cannabis licensees (mainly for the benefit of cultivators).
I wrote a post last year entitled, “Does Medical Licensing Make Sense in Recreational Jurisdictions?” The idea – which we’ve seen borne out countless times – is that in jurisdictions that allow recreational cannabis, medical cannabis usually becomes a relic of the past. That’s because medical cannabis is subject to many more restrictions than recreational
Last month we weighed in on Thailand becoming the first country in Southeast Asia to decriminalize cannabis. We’ve seen some bad reporting on this since then, along the lines of “weed is legal in Thailand!” The new Thai regime is not that progressive, but we still feel that Thailand has taken a step in the
In the 21st century of cannabis, cannabis businesses of all sizes still ignore some contract basics. Whether it’s a cannabis distribution agreement, a cannabis intellectual property licensing agreement, or some form of cannabis M&A, the contract basics listed below need attention. Date the agreement This seems obvious and trivial, but a lot of companies skip
On June 14, the Sixth Panel (Sexta Turma) of Brazil’s Superior Court of Justice (Superior Tribunal de Justiça, or STJ) issued a decision allowing cultivation of cannabis for medical purposes. The STJ is responsible for uniformizing the interpretation of Brazilian federal law across the country, and serves as the court of final appeal for cases
Earlier this month, we discussed the approval of a new regulatory framework for hemp and medical cannabis by Argentina’s legislature. At the time, we focused our attention on those who, reflecting antiquated thinking on cannabis, voted against the bill. Today we finally turn to the substance of what is officially known as the Regulatory Framework
Argentina’s Chamber of Deputies has approved a law to regulate the hemp and medical cannabis industries. According to one of the bill’s sponsors, “a new industry has been born in Argentina” with the passage of the bill (which we flagged last summer in Legalization in Latin America: Who’s Next After Mexico?). The new law enjoyed
Unfazed by the federal leadership vacuum on cannabis, states continue to roll out cannabis proposals and programs. A total of 34 states considered cannabis reform proposals in 2021. Another 32 proposals (some of them pre-filed in 2021) are up for discussion here in 2022. These proposals range from limited decriminalization measures to comprehensive, adult use
